Intervention Summary
Dietary carbohydrate restriction (<40% of total energy, or <130g/day) to reduce hyperinsulinemia — the central metabolic driver of androgen excess in PCOS. Benefits are independent of weight loss, distinguishing this from generic caloric restriction. Also shows evidence for GERD symptom improvement via reduced gastric distension and fermentation.
Evidence
- PCOS meta-analyses: Low-carb diets reduce fasting insulin, HOMA-IR, total testosterone, and LH/FSH ratio compared to standard diets, with improvements in menstrual regularity
- Weight-independent effects: Even isocaloric carbohydrate restriction improves insulin sensitivity and androgen profiles in PCOS
- GERD: Low-carb diets reduce esophageal acid exposure time and GERD symptom scores in overweight patients, independent of weight loss
- Duration: Benefits appear within 4-8 weeks; sustained adherence shows continued improvement at 6-12 months
Mechanism
- Insulin reduction: Lower postprandial glucose reduces insulin secretion, directly decreasing ovarian theca cell androgen production via insulin/IGF-1 receptor signaling
- SHBG increase: Reduced insulin allows hepatic sex hormone-binding globulin (SHBG) production to recover, lowering free testosterone
- Inflammatory reduction: Lower carbohydrate intake reduces postprandial endotoxemia and NF-kB activation
- GERD mechanism: Reduced fermentable carbohydrate decreases gastric gas production and distension, lowering transient lower esophageal sphincter relaxations
Clinical Context
Moderate carbohydrate restriction (80-130g/day) is more sustainable than very low-carb/ketogenic approaches and achieves most of the insulin-sensitizing benefit. Important: Low-carb diets can reduce fiber intake if not carefully planned — practitioners should ensure adequate non-starch polysaccharide intake from low-carb vegetables and targeted fiber supplements (see dietary fiber). Combine with probiotics (see probiotics lactobacillus bifidobacterium) to address dysbiosis concurrently.